Teleflex Secures Premier Agreements for Hemostasis Products with Special Pricing
Portfolio Pulse from Benzinga Newsdesk
Teleflex Incorporated (NYSE:TFX) has secured two group purchasing agreements with Premier, Inc. for its hemostasis products, effective July 1, 2024. These agreements will offer Premier members special pricing and terms for Teleflex's hemostatic portfolio, including QuikClot™ Hemostatic Dressings and Devices.
July 29, 2024 | 10:32 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Premier, Inc. has entered into agreements with Teleflex for special pricing on hemostasis products, effective July 1, 2024. This could enhance Premier's value proposition to its members by offering high-quality products at competitive prices.
The agreements with Teleflex will allow Premier to offer its members high-quality hemostasis products at special pricing, potentially increasing member satisfaction and retention. This could strengthen Premier's position in the group purchasing market.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 80
POSITIVE IMPACT
Teleflex has secured two group purchasing agreements with Premier, Inc. for its hemostasis products, effective July 1, 2024. This could lead to increased sales and market penetration for Teleflex's hemostatic portfolio.
The agreements with Premier, Inc. will provide Teleflex with access to a large network of healthcare providers, potentially increasing sales and market penetration for its hemostasis products. The special pricing and terms could make Teleflex's products more attractive to Premier members.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100